Centessa Pharmaceuticals Plc ADR (CNTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 74,580 | 46,405 | 43,980 | 36,090 | 42,031 |
| Operating Income | -74,580 | -46,405 | -43,980 | -36,090 | -35,178 |
| Interest Expense | 2,479 | 2,557 | 2,525 | 2,529 | 2,570 |
| Other Income | -33,220 | 7,004 | 3,394 | 1,054 | 2,055 |
| Pre-tax Income | -110,279 | -41,958 | -43,111 | -37,565 | -35,693 |
| Income Tax | 1,050 | 608 | 705 | 481 | 1,144 |
| Net Income Continuous | -111,329 | -42,566 | -43,816 | -38,046 | -36,837 |
| Net Income | $-111,329 | $-42,566 | $-43,816 | $-38,046 | $-36,837 |
| EPS Basic Total Ops | -0.91 | -0.37 | -0.40 | -0.38 | -0.38 |
| EPS Basic Continuous Ops | -0.91 | -0.37 | -0.40 | -0.38 | -0.38 |
| EPS Diluted Total Ops | -0.91 | -0.37 | -0.40 | -0.38 | -0.38 |
| EPS Diluted Continuous Ops | -0.91 | -0.37 | -0.40 | -0.38 | -0.38 |
| EPS Diluted Before Non-Recurring Items | -0.34 | -0.37 | -0.40 | -0.38 | N/A |
| EBITDA(a) | $-74,350 | $-46,169 | $-43,744 | $-35,850 | $-41,785 |